Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,969 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,005 | 35 | $0 (2024) |
| Genentech USA, Inc. | $756.46 | 23 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $446.95 | 6 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $361.48 | 3 | $0 (2020) |
| Allergan, Inc. | $267.63 | 3 | $0 (2022) |
| TOPCON MEDICAL SYSTEMS, INC. | $223.79 | 4 | $0 (2017) |
| Astellas Pharma US Inc | $220.42 | 8 | $0 (2024) |
| TissueTech, Inc. | $194.15 | 1 | $0 (2017) |
| Apellis Pharmaceuticals, Inc. | $156.94 | 3 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $124.34 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $763.14 | 23 | Regeneron Healthcare Solutions, Inc. ($310.43) |
| 2023 | $959.84 | 22 | Bausch & Lomb Americas Inc. ($273.08) |
| 2022 | $355.23 | 10 | Regeneron Healthcare Solutions, Inc. ($146.88) |
| 2021 | $139.77 | 6 | Genentech USA, Inc. ($88.55) |
| 2020 | $433.83 | 6 | Allergan, Inc. ($125.00) |
| 2019 | $318.77 | 9 | Aerie Pharmaceuticals, Inc. ($124.99) |
| 2018 | $488.71 | 12 | Genentech USA, Inc. ($220.02) |
| 2017 | $509.66 | 10 | TOPCON MEDICAL SYSTEMS, INC. ($223.79) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $132.46 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/18/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: EYE CARE | ||||||
| 04/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Ophthalmology | ||||||
| 03/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: SOLUTION/ DROPS | ||||||
| 03/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/07/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.59 | General |
| 12/05/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,397 | 7,514 | $1.2M | $735,585 |
| 2022 | 16 | 2,401 | 5,236 | $1.2M | $819,144 |
| 2021 | 17 | 2,321 | 5,066 | $1.2M | $875,043 |
| 2020 | 14 | 1,807 | 4,115 | $973,464 | $721,205 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 45 | 506 | $458,665 | $349,990 | 76.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 11 | 2,640 | $99,911 | $76,904 | 77.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 13 | 374 | $97,046 | $68,056 | 70.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 318 | 762 | $102,788 | $58,706 | 57.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 327 | 365 | $60,175 | $37,063 | 61.6% |
| 92134 | Imaging of retina | Office | 2023 | 522 | 1,079 | $69,577 | $36,379 | 52.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 63 | 296 | $140,675 | $32,931 | 23.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 336 | 439 | $49,684 | $24,948 | 50.2% |
| 92250 | Photography of the retina | Office | 2023 | 482 | 745 | $43,540 | $24,584 | 56.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 19 | 28 | $11,548 | $8,535 | 73.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 67 | 67 | $30,457 | $7,749 | 25.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 114 | 127 | $12,418 | $7,142 | 57.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 19 | 19 | $2,443 | $1,267 | 51.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 39 | 44 | $2,280 | $1,005 | 44.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 22 | 23 | $1,558 | $324.76 | 20.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 51 | 666 | $624,668 | $479,913 | 76.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 14 | 423 | $143,173 | $94,004 | 65.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 294 | 766 | $90,902 | $59,665 | 65.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 68 | 351 | $54,886 | $38,660 | 70.4% |
| 92134 | Imaging of retina | Office | 2022 | 496 | 1,088 | $59,707 | $38,134 | 63.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 303 | 359 | $61,167 | $38,062 | 62.2% |
| 92250 | Photography of the retina | Office | 2022 | 443 | 673 | $48,720 | $22,598 | 46.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 307 | 399 | $44,659 | $18,942 | 42.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 82 | 82 | $20,334 | $9,830 | 48.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 19 | 24 | $9,768 | $7,285 | 74.6% |
About Dr. Robert Klein, MD
Dr. Robert Klein, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174558639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Klein, MD has received a total of $3,969 in payments from pharmaceutical and medical device companies, with $763.14 received in 2024. These payments were reported across 98 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,969).
As a Medicare-enrolled provider, Klein has provided services to 8,926 Medicare beneficiaries, totaling 21,931 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology, Ophthalmology
- Location New York, NY
- Active Since 07/12/2006
- Last Updated 12/03/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1174558639
Products in Payments
- Lucentis (Biological) $524.64
- EYLEA (Biological) $455.14
- MIEBO (Drug) $401.34
- EYLEA HD (Biological) $365.74
- Rhopressa (Drug) $249.99
- DRI-OCT TRITON (Device) $223.79
- Vabysmo (Drug) $209.43
- Prokera (Device) $194.15
- EYLEA AFLIBERCEPT INJECTION (Biological) $183.69
- Syfovre (Drug) $156.94
- LUMIGAN (Drug) $125.00
- LOTEMAX SM (Drug) $124.34
- rhopressa (Drug) $111.49
- Izervay (Drug) $87.31
- BEOVU (Drug) $50.57
- OZURDEX (Drug) $50.39
- XDEMVY (Drug) $42.24
- Simbrinza (Drug) $38.53
- VYZULTA (Drug) $23.08
- XIIDRA (Drug) $22.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054